Susztak K - Search Results

1

Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development.

Kang HM, Ahn SH, Choi P, Ko YA, Han SH, Chinga F, Park AS, Tao J, Sharma K, Pullman J, Bottinger EP, Goldberg IJ, Susztak K. Kang HM, et al. Among authors: susztak k. Nat Med. 2015 Jan;21(1):37-46. doi: 10.1038/nm.3762. Epub 2014 Dec 1. Nat Med. 2015. PMID: 25419705 Free PMC article.

2

Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor beta.

von Gersdorff G, Susztak K, Rezvani F, Bitzer M, Liang D, Böttinger EP. von Gersdorff G, et al. Among authors: susztak k. J Biol Chem. 2000 Apr 14;275(15):11320-6. doi: 10.1074/jbc.275.15.11320. J Biol Chem. 2000. PMID: 10753944 Free article.

3

Smad proteins and transforming growth factor-beta signaling.

Schiffer M, von Gersdorff G, Bitzer M, Susztak K, Böttinger EP. Schiffer M, et al. Among authors: susztak k. Kidney Int Suppl. 2000 Sep;77:S45-52. doi: 10.1046/j.1523-1755.2000.07708.x. Kidney Int Suppl. 2000. PMID: 10997690 Review.

4

Genomic strategies for diabetic nephropathy.

Susztak K, Sharma K, Schiffer M, McCue P, Ciccone E, Böttinger EP. Susztak K, et al. J Am Soc Nephrol. 2003 Aug;14(8 Suppl 3):S271-8. doi: 10.1097/01.asn.0000078035.81397.8a. J Am Soc Nephrol. 2003. PMID: 12874445 Review.

5

Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease.

Susztak K, Böttinger E, Novetsky A, Liang D, Zhu Y, Ciccone E, Wu D, Dunn S, McCue P, Sharma K. Susztak K, et al. Diabetes. 2004 Mar;53(3):784-94. doi: 10.2337/diabetes.53.3.784. Diabetes. 2004. PMID: 14988265

6

Multiple metabolic hits converge on CD36 as novel mediator of tubular epithelial apoptosis in diabetic nephropathy.

Susztak K, Ciccone E, McCue P, Sharma K, Böttinger EP. Susztak K, et al. PLoS Med. 2005 Feb;2(2):e45. doi: 10.1371/journal.pmed.0020045. Epub 2005 Feb 22. PLoS Med. 2005. PMID: 15737001 Free PMC article.

7

Localization of the GLUT8 glucose transporter in murine kidney and regulation in vivo in nondiabetic and diabetic conditions.

Schiffer M, Susztak K, Ranalletta M, Raff AC, Böttinger EP, Charron MJ. Schiffer M, et al. Among authors: susztak k. Am J Physiol Renal Physiol. 2005 Jul;289(1):F186-93. doi: 10.1152/ajprenal.00234.2004. Epub 2005 Mar 1. Am J Physiol Renal Physiol. 2005. PMID: 15741607 Free article.

8

Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.

Susztak K, Raff AC, Schiffer M, Böttinger EP. Susztak K, et al. Diabetes. 2006 Jan;55(1):225-33. Diabetes. 2006. PMID: 16380497

9

Diabetic nephropathy: a frontier for personalized medicine.

Susztak K, Böttinger EP. Susztak K, et al. J Am Soc Nephrol. 2006 Feb;17(2):361-7. doi: 10.1681/ASN.2005101109. Epub 2006 Jan 11. J Am Soc Nephrol. 2006. PMID: 16407421 Review.

10

Poly(ADP-ribose) polymerase inhibitors ameliorate nephropathy of type 2 diabetic Leprdb/db mice.

Szabó C, Biser A, Benko R, Böttinger E, Suszták K. Szabó C, et al. Among authors: susztak k. Diabetes. 2006 Nov;55(11):3004-12. doi: 10.2337/db06-0147. Diabetes. 2006. PMID: 17065336

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

252 results

Search Page

Filters